Eastern Ejiao's first quarter net revenue declined

April 29 evening, East E’Jiao released its quarterly report of 2019. According to the report, the total business income of E’Jiao in the first quarter was about 1.292 billion yuan, a decrease of about 23.83% compared with the same period last year, and its net profit was about 393 million yuan, a decrease of about 35.48% compared with the same period last year. In view of the double decline in net revenue in the first quarter, Donga-Ajiao said that it was mainly due to the reduction of inventory by downstream customers; the company integrated channels, pulled pure sales, controlled delivery, and consolidated terminal quality and foundation. It is worth noting that by the end of March 2019, the share-holding ratio of China Resources Pharmaceutical Investment had increased by 0.33% compared with the end of 2018. China Resources Pharmaceutical Investment and its co-actors, China Resources Donga Jiao, currently hold a total of 207 million shares, accounting for 31.59% of the total share capital of East Asia Asia Jiao.